Hi all - newbie here and my first post.....
First of all let me explain my situation - my youngest daughter has Rett Syndrome and due to this when she was diagnosed I scoured the internet for trials - which brought NNZ-2256 to my attention.
After much research into Neuren and with many comments on this excellent forum - I decided to purchase shares as well (with profits - if any - going to helping my daughter)
Now - the question I have is that although NNZ-2256 seems to be an excellent product and results are very exciting - aren't the results the same as the IGF-1 trial results (https://www.facebook.com/Igf1StudyFamilyUpdates)??
And also sticking my neck out here - as IGF-1 already exists wouldn't this be a cheaper/easier to get drug?
I am thinking that if/when I approach the NHS (from UK) - wouldn't they recommend that I go with the cheaper option that is already available?
Sorry that this isn't a financial query (I am certainly not an expert in either medical or financial matters) but thought I would mention this...
One last thing - does anybody know if there is a process in place once FDA has approved - to get this in the UK???
- Forums
- ASX - By Stock
- NEU
- BT Thought
BT Thought
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.55 |
Change
0.690(3.47%) |
Mkt cap ! $2.583B |
Open | High | Low | Value | Volume |
$20.00 | $20.66 | $19.94 | $4.006M | 197.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 85 | $20.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.57 | 295 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 85 | 20.550 |
3 | 75 | 20.540 |
7 | 342 | 20.530 |
7 | 350 | 20.520 |
5 | 345 | 20.510 |
Price($) | Vol. | No. |
---|---|---|
20.570 | 295 | 5 |
20.580 | 167 | 2 |
20.590 | 163 | 2 |
20.600 | 1220 | 4 |
20.610 | 434 | 5 |
Last trade - 13.43pm 12/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |